Theranos has raised $686.3M in 9 Rounds from 17 Investors.
Interestingly they already refer to their product accuracy as comparable to “gold standards.”
The deck is highly technical. What one might typically expect from a biotech company. This more interesting from an intriguing perspective, rather than for learning on how to write decks.
Theranos (allegedly) makes actionable health information accessible to everyone at the time it matters.
Headquartered in Palo Alto, Theranos, Inc. is a consumer healthcare technology company. Theranos’ clinical laboratory offers comprehensive laboratory tests from samples as small as a few drops of blood at unprecedented low prices. Founded in 2003 by Elizabeth Holmes, Theranos’ mission is to make actionable health information accessible to people everywhere in the world at the time it matters, enabling early detection and intervention of disease, and empowering individuals with information to live the lives they want to live.
|Date||Amount / Round||Valuation||Lead Investor||Investors|
|Dec, 2016||undisclosed amount /Venture||—||—||1|
|Mar, 2015||$348.5M / Private Equity||—||—||9|
|Feb, 2014||$198.9M / Private Equity||—||—||0|
|Sep, 2013||$50M / Undisclosed||—||Walgreens||1|
|Jul, 2010||$45M / Venture||—||—||0|
|Nov, 2006||$28.5M / Series C||—||—||4|
|Feb, 2006||$9.1M / Series B||—||—||1|
|Feb, 2005||$5.8M / Series A||—||—||1|
|Jun, 2004||$500k / Seed||—||Draper Fisher Jurvetson (DFJ)||1|
Theranos Pitch deck
Need help with your deck?
Head over to Perfect Pitch Deck. Competitive pricing and expert assistance to get you fundraise ready and confident.
Want to see the 100 other pitch decks?
If you love pitch decks, check out the ultimate pitch deck collection here!
Looking for something interesting to read
- The real reason founders aren’t funded you will never hear a VC say
- This is how to get introductions to venture capital investors for your startup fundraise
- Why I want a pitch deck before a pitch
- Why you are making a financial model for your fundraise is wrong
- What’s your startup valuation is the wrong question. Here’s why and what the better approach is
Get in the game
Free tools and resources like this shipped to you as they happen.